Susquehanna International Group, LLP Lineage Cell Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$823 Billion
Q3 2025

A detailed history of Susquehanna International Group, LLP transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 185,000 shares of LCTX stock, worth $351,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares

185,000

Previous 547,242 66.19%

Holding current value

$351,500

Previous $497,000 35.61%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$0.87 - $1.79 $315,150 - $648,413	-362,242 Reduced 66.19%	185,000 $320,000
Q2 2025 Aug 14, 2025	BUY	$0.39 - $1.13 $121,341 - $351,580	311,133 Added 131.78%	547,242 $497,000
Q1 2025 May 14, 2025	BUY	$0.45 - $0.72 $77,757 - $124,412	172,795 Added 272.92%	236,109 $106,000
Q4 2024 Feb 14, 2025	BUY	$0.5 - $0.95 $26,159 - $49,702	52,318 Added 475.79%	63,314 $31,000
Q3 2024 Nov 14, 2024	SELL	$0.8 - $1.12 $48,260 - $67,565	-60,326 Reduced 84.58%	10,996 $10,000

Q2 2024 Aug 15, 2024	BUY	$0.89 - $1.47 $32,055 - $52,944	36,017 Added 102.02%	71,322 $71,000
Q1 2024 May 07, 2024	SELL	$0.86 - $1.48 $22,165 - $38,145	-25,774 Reduced 42.2%	35,305 $52,000
Q4 2023 Feb 14, 2024	BUY	$0.91 - $1.35 $55,581 - $82,456	61,079 New	61,079 $66,000
Q2 2023 Aug 11, 2023	SELL	$1.26 - $1.53 $976,759 - $1.19 Million	-775,206 Reduced 94.96%	41,181 $58,000
Q1 2023 May 16, 2023	BUY	$1.2 - $1.53 $771,321 - $983,435	642,768 Added 370.22%	816,387 $1.22 Million
Q4 2022 Feb 14, 2023	BUY	$1.02 - $1.5 $177,091 - $260,428	173,619 New	173,619 $203,000
Q4 2021 Feb 14, 2022	SELL	$1.84 - $2.68 $98,018 - $142,766	-53,271 Reduced 44.5%	66,430 $163,000
Q3 2021 Nov 15, 2021	BUY	$2.26 - $2.86 $106,179 - $134,368	46,982 Added 64.61%	119,701 $302,000
Q2 2021 Aug 11, 2021	SELL	$2.17 - $3.0 $2.01 Million - $2.78 Million	-927,463 Reduced 92.73%	72,719 $207,000
Q1 2021 May 17, 2021	BUY	$1.77 - $3.1 $1.53 Million - $2.68 Million	863,839 Added 633.58%	1,000,182 $2.35 Million
Q4 2020 Feb 16, 2021	BUY	$0.95 - $1.83 $101,043 - $194,642	106,362 Added 354.76%	136,343 $240,000
Q1 2020 May 15, 2020	SELL	$0.6 - $1.58 $17,586 - $46,309	-29,310 Reduced 49.43%	29,981 $25,000
Q4 2019 Feb 14, 2020	SELL	$0.54 - $1.01 $3,795 - $7,099	-7,029 Reduced 10.6%	59,291 $53,000
Q3 2019 Nov 14, 2019	BUY	$0.85 - $1.24 $56,372 - $82,236	66,320 New	66,320 $65,000

Others Institutions Holding LCTX

# of Institutions

128

Shares Held

96M

Call Options Held

251K

Put Options Held

50K

View Full List

About Lineage Cell Therapeutics, Inc.

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $323M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

More about LCTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Lineage Cell Therapeutics, Inc. Transaction History